Arcus Biosciences (RCUS) Interest & Investment Income (2018 - 2026)

Arcus Biosciences' Interest & Investment Income history runs 9 years deep, the most recent figure standing at $9.0 million for Q1 2026.

• In Q1 2026, Interest & Investment Income fell 18.18% year-over-year to $9.0 million; the TTM figure through Mar 2026 stood at $39.0 million (down 22.0% YoY), while the FY2025 annual figure was $41.0 million, down 21.15% from the prior year.
• Interest & Investment Income for Q1 2026 stood at $9.0 million, down from $10.0 million in the prior quarter.
• The five-year high for Interest & Investment Income was $14.0 million in Q3 2024, with the low at $582000.0 in Q1 2022.
• The 5-year median for Interest & Investment Income is $10.0 million (2025), against an average of $9.4 million.
• The sharpest annual moves came in 2022 and 2025: Interest & Investment Income surged 3005.59% in 2022, then slipped 28.57% in 2025.
• Arcus Biosciences' Interest & Investment Income stood at $8.0 million in 2022, then jumped by 37.5% to $11.0 million in 2023, then increased by 9.09% to $12.0 million in 2024, then fell by 16.67% to $10.0 million in 2025, then declined by 10.0% to $9.0 million in 2026.
• Business Quant data shows RCUS's Interest & Investment Income at $9.0 million in Q1 2026, $10.0 million in Q4 2025, and $10.0 million in Q3 2025.